Member Info for havegun

It's a windup.

have derampers like petch007.Best thing is to ignore him and then with nobody bothering to communicate with him he will disappear

nicely positioned now.

may have less time than either of you I'm 72.

Stuart this AM and he says we are still awaiting final approval.How long that is going to take is anyones guess.

Hope you are right it's been a long time.Myself i am still waiting for my Cic Capital fund shares.

Hope there is not A Commie Corbyn Government round the corner because this could sink into the twenties or worse.

Sorry meant this next year

New year everyone and hopefully a prosperous one.Is it going to happen this year with this company who knows.

Ok so we will still have to wait,so what is the point as I say of keep on going on about it?

It is a matter of waiting tiil the trading update at the end of jan.There is no point in going over the same old thing again and again.Please try and stay calm and try to be positive .We and our fellow shareholders all want the same thing which is success for our company..

Always gets me that bitter and twisted people litter boards who are ex holders and just try to run a company down.Instead normal people move on to their next investment.The ones who may hold shares in this company but also run it down,well I feel sorry for them,if they have lost faith they should sell up and leave us alone who believe in the company.

Foxhill doomsayer as one hell of a stutter.

The resident troll not up yet with his negative rubbish.

painted here is like having a Corbyn government in this Country

Derampers are out in force this morning.I wonder if any hold shares in this company,seems doubtful

Debt of over 321 million pounds is going to kill off this company.

Share Tweet Print RSS
IQ-AI Limited (IQAI)
IQ-AI Limited
Installation at Barrow Neurological Institute
RNS Number : 9988J
IQ-AI Limited
11 December 2018

IQ-AI Ltd

("IQ-AI" or the "Company")

Imaging Biometrics® installation at Barrow Neurological Institute

Imaging Biometrics®, LLC ("IB"), a subsidiary of IQ-AI Limited (LON:IQAI), announced today that Barrow Neurological Institute: Dignity Health, St. Joseph's Hospital and Medical Center ("BNI") has installed a new IB Rad Tech software platform to help assess treatment response for patients with brain tumors. BNI has led the way in the development of cutting-edge diagnosis, treatment, and neurosurgical procedures for patients with brain tumors. Every year, Barrow treats thousands of patients with brain tumors, including some of the most difficult cases in the world. IB Rad Tech was chosen for its ability to efficiently generate quantitative maps of enhancing regions of tumor (Delta T1) and fractional tumor burden ("FTB"). IB's perfusion-derived FTB maps have been shown to aid clinicians in distinguishing tumor from non-tumor tissue.

IB Rad Tech offers customised workflows that automate the generation of sophisticated maps, outputs quality assurance indices, and can allow manual acknowledgement and intervention during intermediate processing steps. For example, one workflow used in generating quantitative Delta T1 and FTB maps relies on an exclusive machine-learned calibration technology termed "standardisation", which works for all platforms and field strengths. This step has proven superior to conventional normalisation techniques as it eliminates the need for the manual placement of regions of interest (ROIs) by radiology staff or physicians thereby reducing error and improving workflow efficiencies.

David Smith, CEO of IB, said, "Using this automated normalisation algorithm within an IB Rad Tech workflow enables objective longitudinal assessment and can help assess whether a certain treatment protocol is working for brain tumor patients. Removing the variability of the manually-placed ROI is a more repeatable and faster method to do inter- and intra-study comparisons for multi-center clinical trials as well."

"Without IB Rad Tech, we would not be able to process the high volume of studies we see at our site," said Dr. John Karis, MD, Director of MRI and brain imaging for the Department of Neuroradiology at Barrow Neurological Institute, Dignity Health St. Joseph's Hospital and Medical Center. "Our MR Technologists are now able to quickly and consistently generate IB's advanced maps, and the clinicians trust the science on which Delta T1 and FTBs are based", added Josef Debbins, PhD, Staff Scientist, Keller Center for Imaging Innovation at Barrow.

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please contact:

IQ-AI Limited

Trevor Brown/Vinod Kaushal/Qu Li

Tel: 020 7469 0930

Sorry Lou

Is your first name Bud? You sure are a Comedian.